ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
ARYD was delisted on the 31st of July, 2024.
61 hedge funds and large institutions have $150M invested in ARYA Sciences Acquisition Corp IV Class A Odinary Shares in 2021 Q1 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
91.24% more ownership
Funds ownership: 0% → 91.24% (+91%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$12.5M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10.8M |
| 4 |
TCM
Tybourne Capital Management
Hong Kong
|
+$10.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.64M |
Top Sellers
ARYD Hedge Fund Activity: Q1 2021 in Review
61 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in ARYA Sciences Acquisition Corp IV Class A Odinary Shares (ARYD) for Q1 2021, worth a combined $150M.
Buyers outnumbered sellers: 61 funds opened new ARYD positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $12.5M.
- 61 institutional investors held ARYA Sciences Acquisition Corp IV Class A Odinary Shares (ARYD) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $150M of ARYA Sciences Acquisition Corp IV Class A Odinary Shares stock for Q1 2021.
- 61 funds opened new ARYA Sciences Acquisition Corp IV Class A Odinary Shares positions in Q1 2021 and 0 closed out, a net change of +61 holders.
- The largest ARYA Sciences Acquisition Corp IV Class A Odinary Shares buyer in Q1 2021 was HealthCor Management, an estimated $12.5M added.
Based on aggregated 13F filings for Q1 2021.